Study of Oxaliplatin, Irinotecan, and S-1 in Biliary Tract Cancer

NCT02527824 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

31

Enrollment

OTHER

Sponsor class

Conditions

Biliary Tract Neoplasm

Interventions

DRUG: Oxaliplatin, Irinotecan, S-1

Sponsor

Hallym University Medical Center

Collaborators

[object Object]